BioWorld - Sunday, January 18, 2026

BioWorld Science

June 22, 2021

View Archived Issues

Enrollment opens in phase I study of DCC-3116 in advanced solid tumors with RAS or RAF mutations

Read More

First-in-human study of ChAdOx1 RVF vaccine candidate begins at University of Oxford

Read More

Origo Biopharma patents TGFBR1 inhibitors

Read More

BioNTech initiates first-in-human study of BNT-152 and BNT-153 in solid tumors

Read More

Medshine Discovery discloses Chk1 inhibitors for pancreatic cancer

Read More

New GTPase KRAS mutant inhibitors presented by Taiho Pharmaceutical

Read More

Lunan Pharmaceutical Group describes oleanane cinnamamide derivatives

Read More

European researchers identify CaSR-targeting antibodies

Read More

City of Hope National Medical Center presents FIH data on COH04S1 vaccine

Read More

Promising data reported from CYAD-211 IMMUNICY-1 trial

Read More

Initial phase I data on Betalutin in relapsed/refractory DLBCL

Read More

Phase II trial of Auxora in patients with acute pancreatitis and accompanying SIRS and hypoxemia

Read More

Stimulation of optic nerve activity increases optic glioma growth in mice with Nf1 mutations

Read More

Results from first-in-human study of AO-176 in advanced solid tumors

Read More

STING inhibitors target inflammatory diseases

Read More

Anti-COX-2 Ab is a novel highly specific diagnostic marker in immune aplastic anemia

Read More

Sanofi Pasteur and Translate Bio begin phase I trial of mRNA seasonal influenza vaccine

Read More

Dicerna begins phase II study of belcesiran for AAT deficiency-associated liver disease

Read More